نتایج جستجو برای: lap non alcoholic fatty liver disease obesity
تعداد نتایج: 3012383 فیلتر نتایج به سال:
nonalcoholic fatty liver disease (nafld) is one of the aspects of metabolic syndrome (mets). due to the increase of mets in iran, this study was conducted to determine the prevalence of nafld, its potential predictors and their sex distribution in north of iran, amol.in 2008 this population based cross-sectional study included 5023 adult individuals who were randomly selected from amol healthca...
nonalcoholic fatty liver disease (nafld) is an obesity-associated disease and dysregulation of adipokines has an important role in its development. omentin-1 (itln1 protein) and resistin are two adipokine secreted from adipose tissue. single nucleotide polymorphisms in the adipokine genes may affect expression and activity of the adipokine, and thus play a contributory role in nafld pathogenesi...
Background: Non-alcoholic fatty liver disease is one of the most important chronic liver disorders worldwide. Adipokines are polypeptide hormones that participate in the pathogenesis of non-alcoholic fatty liver disease. Adiponectin is an adipokine that stimulates fatty acid oxidation in muscle and plays a role in the development of insulin sensitivity. This study aimed to investigate the assoc...
background: non-alcoholic fatty liver disease (nafld) is increasingly a common disease which is created by the accumulation of fat in the liver. about 20% of adults and 5% of children suffer from this disease. in some studies, half of obese children had fatty liver disease and approximately 90% of the patients with fatty liver were obese. the aim of this study was to evaluate fatty liver diseas...
Background: The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing due to the growing epidemics of obesity. Omentin-1 is an anti-inflammatory adipokine produced preferentially by visceral adipose tissue. The aim of this study was to determine omentin-1 serum levels and its relationship with body mass index, fasting blood sugar and lipid profile. Materials and methods: This cas...
Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease is increasing in adults and children worldwide. Obesity, insulin resistance or diabetes type II, hyperlipidemia and hypertriglyceridemia plays a major role in the epidemiology of this disease. Cytokeratin 18 (CK-18) the major intermediate filament protein in the liver is a marker of increased hepatocyte apoptosis. ...
background nonalcoholic fatty liver disease (nafld) is one of the most common reasons of enzyme increase in liver. in about 10 percent of patients with nafld, the disease progresses toward non alcoholic steatohepatitis (nash) and about one third of them may progress toward cirrhosis, liver dysfunction, and even hepatocellular carcinoma. objectives according to high prevalence of nafld and the f...
conclusions our results showed for the first time that lyplal1 gene is not associated with a risk of nafld development in the chinese han population. the variant carriers of overall subjects significantly increased weight, bmi and ldl. patients and methods lyplal1 rs12137855 gene was genotyped in 184 patients with nafld and 114 healthy controls using sequencing and polymerase chain reaction ana...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید